From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Open accessThe DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Abstract
The lymphatic system serves an integral role in fluid homeostasis, lipid metabolism and immune control. In cancer, the lymph nodes that drain solid tumours are a primary site of metastasis, and recent studies have suggested intrinsic links between lymphatic function, lipid deposition, obesity and atherosclerosis. Advances in the current understanding of the role of the lymphatics in pathological change and immunity have driven the recognition that lymph-targeted delivery has the potential to transform disease treatment and vaccination. In addition, the design of lymphatic delivery systems has progressed from simple systems that rely on passive lymphatic access to sophisticated structures that use nanotechnology to mimic endogenous macromolecules and lipid conjugates that 'hitchhike' onto lipid transport processes. Here, we briefly summarize the lymphatic system in health and disease and the varying mechanisms of lymphatic entry and transport, as well as discussing examples of lymphatic delivery that have enhanced therapeutic utility. We also outline future challenges to effective lymph-directed therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The lymphatic route also exposes lymph-resident tissues, including the mesenteric lymph nodes and circulating lymphocytes, to drug concentrations far higher than those measured in systemic plasma, a property now exploited deliberately for lymph-targeted therapy but also a source of disconnect between plasma-based scaling and tissue exposure [32].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198
On the Absorption of Fluids from the Connective Tissue Spaces
Starling, E. H. (1896) · The Journal of Physiology · doi:10.1113/jphysiol.1896.sp000596 · Cited by 2,148
CX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611
LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., & Jackson, D. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.789 · Cited by 1,583
Cited by
Items 301–400 of 653
Nanomedicine Approaches Against Parasitic Worm Infections
Li, P., Coronado, P. E. R., Longstaff, X. R., Tarashansky, A. J., & Wang, B. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701494 · Cited by 23
Lee, G., Han, S., Lu, Z., Hong, J., Phillips, A. R. J., Windsor, J. A., Porter, C. J. H., & Trevaskis, N. L. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120247 · Cited by 28
Self-citationWang, X., Zhang, C., Han, N., Luo, J., Zhang, S., Wang, C., Jia, Z., & Du, S. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1960928 · Cited by 23
de Oliveira, T. C., Tavares, M. E. V., Soares‐Sobrinho, J. L., & Chaves, L. L. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103110 · Cited by 26
Novel strategies for the treatment of acute pancreatitis based on the determinants of severity
Windsor, J. A., Escott, A. B. J., Brown, L. A., & Phillips, A. R. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13784 · Cited by 23
Advances in nanocarriers for targeted drug delivery and controlled drug release
Wang, Y., Huang, R., Feng, S., & Mo, R. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60861-2 · Cited by 50
Interplay between Gut Lymphatic Vessels and Microbiota
Solari, E., Marcozzi, C., Negrini, D., & Moriondo, A. (2021) · Cells · doi:10.3390/cells10102584 · Cited by 23
Coagulation in Lymphatic System
Zhang, W., Li, J., Liang, J., Qi, X., Tian, J.-H., & Liu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.762648 · Cited by 24
Yadav, P., McLeod, V. M., Nowell, C. J., FitzGerald, L. I., Johnston, A. P. R., Kaminskas, L. M., & Trevaskis, N. L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.031 · Cited by 22
Self-citationLymph-directed nitric oxide increases immune cell access to lymph-borne nanoscale solutes
Sestito, L. F., & Thomas, S. N. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120411 · Cited by 23
Zheng, B., Pan, F., Shi, M., He, C., He, B., Wang, R., Ren, G., Yang, S., & Zhang, S. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s462374 · Cited by 24
Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent
Stylianou, V. V., Bertram, K. M., Vo, V. A., Dunn, E. B., Baharlou, H., Terre, D. D., Elhindi, J., Elder, E. E., French, J. R., Meybodi, F., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174144 · Cited by 27
Progress in cancer vaccines enabled by nanotechnology
Kim, B., Abdelfattah, N. S., Hostetler, A., & Irvine, D. J. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-02021-z · Cited by 24
Yin, Y. B., Yang, J., Pan, Y., Guo, Z., Gao, Y., Huang, L., Zhou, D., Ge, Y., Guo, F., Zhu, W., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa200 · Cited by 21
Strategies for enhancing the oral bioavailability of cannabinoids
Bar-Hai, A., Domb, A. J., & Hoffman, A. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2099837 · Cited by 23
Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles
Dai, Y., Yu, X. M., Leng, Y., Peng, X., Wang, J., Zhao, Y., Chen, J., & Zhang, Z. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02026-7 · Cited by 23
Pooja, D., Kadari, A., Kulhari, H., & Sistla, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813687-4.00013-x · Cited by 21
Adiwidjaja, J., Boddy, A. V., & McLachlan, A. J. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02834-8 · Cited by 22
Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
Reddiar, S. B., Xie, Y., Abdallah, M., Han, S., Hu, L., Feeney, O. M., Gracia, G., Anshabo, A., Lu, Z., Farooq, M. A., et al. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001159 · Cited by 21
Self-citationRyu, S.-J., Jin, M., Lee, H.-K., Wang, M., Baek, J.-S., & Cho, C. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00557-5 · Cited by 20
Lam, A. D., Cao, E., Leong, N. J., Gracia, G., Porter, C. J. H., Feeney, O. M., & Trevaskis, N. L. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.02.014 · Cited by 20
Self-citationSui, Y., Li, J., Qu, J., Fang, T., Zhang, H., Zhang, J., Wang, Z., Xia, M., Dai, Y., & Wang, D. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.05.004 · Cited by 20
Fu, X., Fu, S., Cai, Z., Jin, R., Xia, C., Lui, S., Song, B., Gong, Q., & Ai, H. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01885c · Cited by 20
Sestito, L. F., To, K., Cribb, M. T., Archer, P. A., Thomas, S. N., & Dixon, J. B. (2023) · Science Advances · doi:10.1126/sciadv.abq0435 · Cited by 22
Yavuz, A., Coiffier, C., Garapon, C., Gürcan, S., Monge, C., Exposito, J., Arruda, D. C., & Verrier, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15031009 · Cited by 23
Drakes, D. J., Abbas, A. M., Shields, J. D., Steinbuck, M. P., Jakubowski, A., Seenappa, L. M., Haqq, C. M., & DeMuth, P. C. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0978 · Cited by 24
Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines
Song, K., & Pun, S. H. (2024) · BME Frontiers · doi:10.34133/bmef.0038 · Cited by 20
The Gut-Lymph Model Gives New Treatment Strategies for Organ Failure
Windsor, J. A., Trevaskis, N. L., & Phillips, A. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.0654 · Cited by 20
Self-citationLipophilicity in Drug Development: Too Much or Not Enough?
Bergström, C. A. S., & Yazdanian, M. A. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9947-5 · Cited by 20
Optimal range of injection rates for a lymphatic drug delivery system
FUJII, H., Horie, S., TAKEDA, K., Mori, S., & Kodama, T. (2018) · Journal of Biophotonics · doi:10.1002/jbio.201700401 · Cited by 20
Omura, S., Kawai, E., Sato, F., Martinez, N. E., Minagar, A., Al‐Kofahi, M., Yun, J. W., Cvek, U., Trutschl, M., Alexander, J. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02870 · Cited by 23
Wang, Y., Guo, X., Qin, J., Xue, Y., Zhang, P., Liu, Y., Chen, M., Zhu, G., Song, X., Cheng, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202500139 · Cited by 25
Systemic effects in naïve mice injected with immunomodulatory lectin ArtinM
Brito, P. K. M. O., Gonçalves, T. E., Fernandes, F. F., Miguel, C. B., Rodrigues, W. F., Chica, J. E. L., Roque‐Barreira, M. C., & da Silva, T. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187151 · Cited by 19
68Ga-labeled amphiphilic polymer nanoparticles for PET imaging of sentinel lymph node metastasis
Chen, Q., Fu, X., Cai, H., Fu, S., Cai, Z., Li, M., Wu, X., Tian, R., & Ai, H. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad029 · Cited by 19
Liu, Z., Wang, Q., Feng, Y., Zhao, L., Dong, N., Zhang, Y. X., Yin, T., He, H., Tang, X., Gou, J., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146474 · Cited by 19
Battle of the milky way: Lymphatic targeted drug delivery for pathogen eradication
Taheri, A., Bremmell, K. E., Joyce, P. M., & Prestidge, C. A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.002 · Cited by 21
Longobardi, G., Moore, T. L., Conte, C., Ungaro, F., Satchi‐Fainaro, R., & Quaglia, F. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1990 · Cited by 22
Physiological Perspective on Therapies of Lymphatic Vessels
Kilarski, W. W. (2018) · Advances in Wound Care · doi:10.1089/wound.2017.0768 · Cited by 21
Karthika, C., & Sureshkumar, R. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109325 · Cited by 21
The glymphatic system and subarachnoid hemorrhage: disruption and recovery
Quintin, S. S., Barpujari, A., Mehkri, Y., Hernandez, J. S., & Lucke-Wold, B. P. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00023 · Cited by 21
Pan, S., Yuan, H., Zhai, Q., Zhang, Y., He, H., Yin, T., Tang, X., & Gou, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.011 · Cited by 22
Almasri, R., Joyce, P. M., Schultz, H. B., Thomas, N., Bremmell, K. E., & Prestidge, C. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070687 · Cited by 20
Fukumura, R., Sukhbaatar, A., Mishra, R., Sakamoto, M., Mori, S., & Kodama, T. (2021) · Cancer Science · doi:10.1111/cas.14867 · Cited by 18
Lymphatic targeting for therapeutic application using nanoparticulate systems
Singh, N., Handa, M., Singh, V., Kesharwani, P., & Shukla, R. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2092741 · Cited by 20
In Vitro Models of Blood and Lymphatic Vessels—Connecting Tissues and Immunity
Bogseth, A., Ramirez, A., Vaughan, E., & Maisel, K. (2022) · Advanced Biology · doi:10.1002/adbi.202200041 · Cited by 20
Biomaterial-based strategies to prime dendritic cell-mediated anti-cancer immune responses
Park, W., Song, K. H., Lim, J., Park, C. G., Doh, J., & Han, D. K. (2020) · International Materials Reviews · doi:10.1080/09506608.2020.1735117 · Cited by 19
Izgelov, D., Regev, A., Domb, A. J., & Hoffman, A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00141 · Cited by 20
The choice of anti-tumor strategies based on micromolecules or drug loading function of biomaterials
Liu, C., Zhang, T., Chen, L., & Chen, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.019 · Cited by 19
Velluto, D., Bojadzic, D., Toni, T. D., Buchwald, P., & Tomei, A. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.026 · Cited by 18
Chan, L. J., Feeney, O. M., Leong, N. J., McLeod, V. M., Porter, C. J. H., Williams, C. C., & Kaminskas, L. M. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00794 · Cited by 18
Self-citationThe Evolution of Mammalian Adipose Tissues
Pond, C. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-52031-5_1 · Cited by 24
Zheng, W., Li, S., Shi, Z., Su, K., Ding, Y., Zhang, L., Tang, Q., Han, J., Zhao, H., Wang, F., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02837-2 · Cited by 18
Sailor, G. U. (2021) · Springer eBooks · doi:10.1007/978-981-33-4497-6_10 · Cited by 26
Du, Y., Shi, J., Duan, R., Tsim, K. W. K., Shen, L., Zhang, N., & Wang, B. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213069 · Cited by 22
Fernandes, L. D. R., Lopes, J. R., Bonjorno, A. F., Prates, J. L. B., Scarim, C. B., & dos Santos, J. L. (2023) · Viruses · doi:10.3390/v15112234 · Cited by 20
Manganese-Doped Potassium Chloride Nanoelectrodes to Potentiate Electrochemical Immunotherapy
Wang, G., Li, J., Wang, L., Yang, Y., Wu, J., Tang, W., Lei, H., & Cheng, L. (2024) · ACS Nano · doi:10.1021/acsnano.4c01132 · Cited by 21
Deconstructing Immune Microenvironments of Lymphoid Tissues for Reverse Engineering
Witzel, I., Nasser, R. A., Garcia‐Sabaté, A., Sapudom, J., Ma, C., Chen, W., & Teo, J. C. M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801126 · Cited by 17
Wu, Y., Jin, Q., Chen, Y., Li, H., Deng, C., Sun, Z., Li, Y., Wang, B., Li, H., Wu, C., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm01028f · Cited by 18
Gomi, M., Sakurai, Y., Okada, T., Miura, N., Tanaka, H., & Akita, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.014 · Cited by 18
Dyavar, S. R., Kumar, S., Gautam, N., Podany, A. T., Winchester, L. C., Weinhold, J. A., Mykris, T. M., Nallasamy, P., Alnouti, Y., & Fletcher, C. V. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab228 · Cited by 19
Deng, C., Jin, Q., Wu, Y., Li, H., Yi, L., Chen, Y., Gao, T., Wang, W., Wang, J., Lv, Q., et al. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1968978 · Cited by 17
iNKT cell agonists as vaccine adjuvants to combat infectious diseases
Li, Y., Yan, C., Luo, R., & Liu, Z. (2022) · Carbohydrate Research · doi:10.1016/j.carres.2022.108527 · Cited by 17
Cao, E., Lindgren, A., Martinsson, S., Hu, L., Lindfors, L., Sigfridsson, K., Skantze, U., Michaëlsson, E., Trevaskis, N. L., & Porter, C. J. H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.002 · Cited by 18
Self-citationRecent Advances in the Design of Self‐Delivery Amphiphilic Drugs and Vaccines
Xi, J., & Liu, H. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900107 · Cited by 16
Subcutaneous delivery of a dendrimer-BH3 mimetic improves lymphatic uptake and survival in lymphoma
Feeney, O. M., Ardipradja, K., Noi, K. F., Mehta, D. C., Rose, R. D., Yuen, D., Johnston, A. P. R., Kingston, L. P., Ericsson, C., Elmore, C. S., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.041 · Cited by 16
Self-citationFluorescent Tracers for In Vivo Imaging of Lymphatic Targets
Russell, P. S., Velivolu, R., Maldonado-Zimbrón, V. E., Hong, J., Kavianinia, I., Hickey, A. J., Windsor, J. A., & Phillips, A. R. J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.952581 · Cited by 20
Seenappa, L. M., Jakubowski, A., Steinbuck, M. P., Palmer, E., Haqq, C. M., Carter, C., Fontenot, J. A., Villinger, F. J., McNeil, L. K., & DeMuth, P. C. (2022) · npj Vaccines · doi:10.1038/s41541-022-00560-3 · Cited by 17
Sakurai, Y., Ohtani, A., Nakayama, Y., Gomi, M., Masuda, T., Ohtsuki, S., Tanaka, H., & Akita, H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.043 · Cited by 16
Demartis, S., Rassu, G., Anjani, Q. K., Volpe‐Zanutto, F., Hutton, A. R. J., Sabri, A. H. B., McCarthy, H. O., Giunchedi, P., Donnelly, R. F., & Gavini, E. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.048 · Cited by 16
Cao, S., Budina, E., Wang, R., Sabados, M., Mukherjee, A., Solanki, A., Nguyen, M., Hultgren, K., Dhar, A., & Hubbell, J. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.027 · Cited by 16
Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications
Liang, J., Yao, L., Liu, Z., Chen, Y., Lin, Y., & Tian, T. (2024) · Small · doi:10.1002/smll.202407649 · Cited by 20
McEvoy, C. L., Trevaskis, N. L., Feeney, O. M., Edwards, G. A., Perlman, M. E., Ambler, C. M., & Porter, C. J. H. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00660 · Cited by 17
Self-citationRychlicka, M., Niezgoda, N., & Gliszczyńska, A. (2020) · Catalysts · doi:10.3390/catal10050588 · Cited by 16
Optimal delivery strategies for nanoparticle-mediated mRNA delivery
Li, X., Guo, X., Hu, M., Cai, R., & Chen, C. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02455a · Cited by 17
Reductionist Three-Dimensional Tumor Microenvironment Models in Synthetic Hydrogels
Katz, R. R., & West, J. L. (2022) · Cancers · doi:10.3390/cancers14051225 · Cited by 15
Fabrication of subunit nanovaccines by physical interaction
Chen, H., Liu, H., Liu, L., & Chen, Y. (2022) · Science China Technological Sciences · doi:10.1007/s11431-021-2011-7 · Cited by 17
Hou, L., Peng, X., Wang, R., Wang, Y., Li, H., Zhang, H., Zhang, Y., & Zhang, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.014 · Cited by 16
Harisa, G. I., Sherif, A. Y., & Alanazi, F. K. (2023) · The Journal of Membrane Biology · doi:10.1007/s00232-023-00280-2 · Cited by 16
Intestinal Lymphatic Dysfunction in Kidney Disease
Zhong, J., Kirabo, A., Yang, H., Fogo, A. B., Shelton, E. L., & Kon, V. (2023) · Circulation Research · doi:10.1161/circresaha.122.321671 · Cited by 17
Kocabiyik, O., Amlashi, P., Vo, A. L., Suh, H., Rodriguez‐Aponte, S. A., Dalvie, N. C., Love, J. C., Andrabi, R., & Irvine, D. J. (2024) · Science Advances · doi:10.1126/sciadv.adn7786 · Cited by 18
Ghaznavi, A., Xu, J., Lee, C. U., & Hara, S. A. (2024) · Advanced Materials Technologies · doi:10.1002/admt.202400286 · Cited by 15
Yousef, M., Bou‐Chacra, N. A., Löbenberg, R., & Davies, N. M. (2024) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2024.107548 · Cited by 16
Han, S., Quach, T., Hu, L., Lim, S. F., Gracia, G., Trevaskis, N. L., Simpson, J. S., & Porter, C. J. H. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.021 · Cited by 16
Self-citationLymphatic Drug Transport and Associated Drug Delivery Technologies: A Comprehensive Review
Punjabi, M. S., Naha, A., Shetty, D., & Nayak, U. Y. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826999201203214247 · Cited by 16
A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
Ross, B. D., Jang, Y., Welton, A. R., Bonham, C. A., Palagama, D. S. W., Heist, K., Boppisetti, J., Imaduwage, K. P., Robison, T. H., King, L. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32486-8 · Cited by 16
Drug Formulation and Nanomedicine Approaches to Targeting Lymphatic Cancer Metastases
Wang, L., Subasic, C. N., Minchin, R. F., & Kaminskas, L. M. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0478 · Cited by 16
Self-citationArora, M., Ganugula, R., Kumar, N., Kaur, G., Pellois, J., Garg, P., & Kumar, M. N. V. R. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00419 · Cited by 15
Tumor Antigen-Based Nanovaccines for Cancer Immunotherapy: A Review
Zhao, J., Du, G., & Sun, X. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3178 · Cited by 15
Nagaoka, M., Liao, W., Kusamori, K., & Nishikawa, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031350 · Cited by 14
Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats
Kelly, K. A., Heaps, C. L., Wu, G., Labhasetwar, V. D., & Meininger, C. J. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.04.009 · Cited by 15
Rudd, D. A., Benkendorff, K., Chahal, C., Guinan, T. M., Gustafsson, O., Esmaeelian, B., Krysinska, H., Pogson, L. D., Voelcker, N. H., & Abbott, C. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-48533-2 · Cited by 16
Annu, Baboota, S., & Ali, J. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102272 · Cited by 23
Drug delivery to the intestinal lymph by oral formulations
Yoshida, T., Kojima, H., Sako, K., & Kondo, H. (2022) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2022.2030353 · Cited by 15
Sukhbaatar, A., Mori, S., & Kodama, T. (2022) · Cancer Science · doi:10.1111/cas.15283 · Cited by 14
Tian, C., Guo, J., Miao, Y.-F., Wang, H., Ye, Q., Guo, C., Zhang, M., He, Z., & Sun, J. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.05.015 · Cited by 14
Harisa, G. I., Sherif, A. Y., Alanazi, F. K., Ali, E. A., Omran, G. A., Nasr, F. A., Attia, S. M., & Alqahtani, A. S. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113148 · Cited by 16
Landh, E., Moir, L. M., Traini, D., Young, P. M., & Ong, H. X. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0192 · Cited by 14
FUJII, H., Horie, S., Sukhbaatar, A., Mishra, R., Sakamoto, M., Mori, S., & Kodama, T. (2019) · Cancer Medicine · doi:10.1002/cam4.2125 · Cited by 15
The expanding role of formulations to enable oral delivery of poorly water-soluble drugs
Ueda, K., Porter, C. J. H., Goodwin, A. K., & Taylor, L. S. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01407-5 · Cited by 21
Self-citationMikrani, R., Styles, I. K., Hoang, T. A., Abdallah, M., Senyschyn, D., Porter, C. J. H., Cao, E., & Trevaskis, N. L. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.10.019 · Cited by 14
Self-citation
Metadata
- Authors
- Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-10-16
- Volume
- 14
- Issue
- 11
- Pages
- 781-803
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2204416339
- Cited by
- 654
- References
- 287
- Citations by year
- 2026: 43 · 2025: 59 · 2024: 66 · 2023: 71 · 2022: 76 · 2021: 95 · 2020: 81 · 2019: 61 · 2018: 42 · 2017: 38 · 2016: 20 · 2015: 1
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- green
- research.monash.edu
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- lymph node targeting, lymphatic drug delivery, lymphatic system, nanotechnology, lipid conjugates, prophylactic vaccination, therapeutic vaccination, tolerance induction, metastasis, lymph nodes, obesity, atherosclerosis, bioavailability, drug development
- MeSH terms
- Animals, Biological Transport, Humans, Lymphatic System, Neoplasms, Prodrugs, Drug Delivery Systems, Lymphatic Vessels, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.